Skip to main content
Top
Published in: Rheumatology International 3/2007

01-01-2007 | Original Article

Survival study by organ disorders in 306 Japanese patients with systemic lupus erythematosus: results from a single center

Authors: M. Funauchi, H. Shimadzu, C. Tamaki, T. Yamagata, Y. Nozaki, M. Sugiyama, S. Ikoma, K. Kinoshita

Published in: Rheumatology International | Issue 3/2007

Login to get access

Abstract

Survival rate and causes of death according to the period of diagnosis and four accompanying organ disorders were analyzed in 306 Japanese patients with systemic lupus erythematosus. The survival rate was gradually improved, and the survival rate during 5- and 10-year periods of the patients diagnosed in 1990–2004 was 94 and 92%, 20-year period of those in 1980–1989 was 77%, 30-year period of those in 1975–1979 was 71%, respectively. Survival rate of those with serositis, pulmonary hypertension, and positive family history tended to be reduced, while that of the cases with neuropsychiatric disorder and renal disorder was significantly reduced. Overlapping of these organ disorders was an important factor for a poor prognosis. Bronchopneumonia and cerebrovascular accidents were frequent causes of death, and treatment for anti-phospholipid antibody syndrome and life-style diseases such as hypertension and arteriosclerosis was thought to be important for a good outcome.
Literature
1.
go back to reference Urowitz MB, Gladman DD, Abu-Shakra M, Farewell VT (1997) Mortality studies in systemic lupus erythematosus. Results from a single center. III. Improved survival over 24 years. J Rheumatol 24:1061–1065 Urowitz MB, Gladman DD, Abu-Shakra M, Farewell VT (1997) Mortality studies in systemic lupus erythematosus. Results from a single center. III. Improved survival over 24 years. J Rheumatol 24:1061–1065
2.
go back to reference Mok CC, Mak A, Chu WP, To CH, Wong SN (2005) Long-term survival of southern Chinese patients with systemic lupus erythematosus: a prospective study of all age-groups. Medicine (Baltimore) 84:218–224 Mok CC, Mak A, Chu WP, To CH, Wong SN (2005) Long-term survival of southern Chinese patients with systemic lupus erythematosus: a prospective study of all age-groups. Medicine (Baltimore) 84:218–224
3.
go back to reference Kataoka H, Koike T (2004) Lupus mortality in Japan. Autoimmun Rev 3:421–422 Kataoka H, Koike T (2004) Lupus mortality in Japan. Autoimmun Rev 3:421–422
4.
go back to reference Kaslow RA, Masi AT (1978) Age, sex, and race effects on mortality from systemic lupus erythematosus in the United States. Arthritis Rheum 21:473–479 Kaslow RA, Masi AT (1978) Age, sex, and race effects on mortality from systemic lupus erythematosus in the United States. Arthritis Rheum 21:473–479
5.
go back to reference Jönsen A, Bengtsson A, Nived O, Ryberg B, Sturfelt G (2002) Outcome of neuropsychiatric systemic lupus erythematosus within a defined Swedish population: increased morbidity but low mortality. Rheumatology 41:1308–1312 Jönsen A, Bengtsson A, Nived O, Ryberg B, Sturfelt G (2002) Outcome of neuropsychiatric systemic lupus erythematosus within a defined Swedish population: increased morbidity but low mortality. Rheumatology 41:1308–1312
6.
go back to reference Swaak AJG, van den Brink HG, Smeenk RJ, Manger K, Kalden JR, Tosi S, Marchesoni A, Domljan Z, Rozman B, Logar D, Pokorny G, Kovacs L, Kovacs A, Vlachoyiannnopoulos PG, Moutsopoulos HM, Chwalinska-Sadowska H, Dratwianka B, Kiss E, Cikes N, Branimir A, Schneider M, Fischer R, Bombardieri S, Mosca M, Smolen JS (1999) Systemic lupus erythematosus: clinical features in patients with a disease duration of over 10 years, first evaluation. Rheumatology 38:953–958 Swaak AJG, van den Brink HG, Smeenk RJ, Manger K, Kalden JR, Tosi S, Marchesoni A, Domljan Z, Rozman B, Logar D, Pokorny G, Kovacs L, Kovacs A, Vlachoyiannnopoulos PG, Moutsopoulos HM, Chwalinska-Sadowska H, Dratwianka B, Kiss E, Cikes N, Branimir A, Schneider M, Fischer R, Bombardieri S, Mosca M, Smolen JS (1999) Systemic lupus erythematosus: clinical features in patients with a disease duration of over 10 years, first evaluation. Rheumatology 38:953–958
7.
go back to reference Miettunen PM, Ortiz-Alvarez O, Petty RE, Cimaz R, Malleson PN, Cabral DA, Ensworth S, Tucker LB (2004) Gender and ethnic origin have no effect on longterm outcome of childhood-onset systemic lupus erythematosus. J Rheumatol 31:1650–1651 Miettunen PM, Ortiz-Alvarez O, Petty RE, Cimaz R, Malleson PN, Cabral DA, Ensworth S, Tucker LB (2004) Gender and ethnic origin have no effect on longterm outcome of childhood-onset systemic lupus erythematosus. J Rheumatol 31:1650–1651
8.
go back to reference Manger K, Manger B, Repp R, Geisselbreacht M, Geiger A, Pfahlberg A, Harrer T, Kalden JR (2002) Definition of risk factors for death, end stage renal disease, and thrombotic events in a monocentric cohort of 338 patients with systemic lupus erythematosus. Ann Rheum Dis 61:1065–1070 Manger K, Manger B, Repp R, Geisselbreacht M, Geiger A, Pfahlberg A, Harrer T, Kalden JR (2002) Definition of risk factors for death, end stage renal disease, and thrombotic events in a monocentric cohort of 338 patients with systemic lupus erythematosus. Ann Rheum Dis 61:1065–1070
9.
go back to reference Nived O, Jonsen A, Bengtsson AA, Bengtsson C, Stunfelt G (2002) High predictive value of the systemic lupus International Collaborators Clinics/American College of Rheumatology damage index for survival in systemic lupus erythematosus. J Rheumatol 29:1398–1400 Nived O, Jonsen A, Bengtsson AA, Bengtsson C, Stunfelt G (2002) High predictive value of the systemic lupus International Collaborators Clinics/American College of Rheumatology damage index for survival in systemic lupus erythematosus. J Rheumatol 29:1398–1400
10.
go back to reference Gladman DD, Urowitz MB, Rahman P, Ibanez D, Tam LS (2003) Accrual of organ damage over time in patients with systemic lupus erythematosus. J Rheumatol 30:1955–1959 Gladman DD, Urowitz MB, Rahman P, Ibanez D, Tam LS (2003) Accrual of organ damage over time in patients with systemic lupus erythematosus. J Rheumatol 30:1955–1959
11.
go back to reference Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277 Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277
12.
go back to reference Zar JH (1984) Biostatistical analysis. Prentice-HaIl, Englewood Cliffs, NJ Zar JH (1984) Biostatistical analysis. Prentice-HaIl, Englewood Cliffs, NJ
13.
go back to reference Boumpas DT, Fessler BJ, Austin HA 3rd, Balow JE, Klippel JH, Lockshin MD (1995) Systemic lupus erythematosus: emerging concepts. Part 2: dermatologic and joint disease, the antiphospholipid antibody syndrome, pregnancy and hormonal therapy, morbidity and mortality, and pathogenesis. Ann Intern Med 123:42–53 Boumpas DT, Fessler BJ, Austin HA 3rd, Balow JE, Klippel JH, Lockshin MD (1995) Systemic lupus erythematosus: emerging concepts. Part 2: dermatologic and joint disease, the antiphospholipid antibody syndrome, pregnancy and hormonal therapy, morbidity and mortality, and pathogenesis. Ann Intern Med 123:42–53
14.
go back to reference Johnson SR, Gladman DD, Urowitz MB, Ibanez D, Granton JT (2004) Pulmonary hypertension in systemic lupus. Lupus 13:506–509 Johnson SR, Gladman DD, Urowitz MB, Ibanez D, Granton JT (2004) Pulmonary hypertension in systemic lupus. Lupus 13:506–509
15.
go back to reference Winslow TM, Ossipov MA, Fazio GP, Simonson JS, Redberg RF, Schiller NB (1995) Five-year follow-up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosus. Am Heart J 129:510–515 Winslow TM, Ossipov MA, Fazio GP, Simonson JS, Redberg RF, Schiller NB (1995) Five-year follow-up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosus. Am Heart J 129:510–515
16.
go back to reference Kasukawa R, Nishimaki T, Takagi T, Miyawaki S, Yokohari R, Tsunematsu T (1990) Pulmonary hypertension in connective tissue disease. Clinical analysis of sixty patients in multi-institutional study. Clin Rheumatol 9:56–62 Kasukawa R, Nishimaki T, Takagi T, Miyawaki S, Yokohari R, Tsunematsu T (1990) Pulmonary hypertension in connective tissue disease. Clinical analysis of sixty patients in multi-institutional study. Clin Rheumatol 9:56–62
17.
go back to reference Simonson JS, Schiller NB, Petri M, Hellmann DB (1989) Pulmonary hypertension in systemic lupus erythematosus. J Rheumatol 16:918–925 Simonson JS, Schiller NB, Petri M, Hellmann DB (1989) Pulmonary hypertension in systemic lupus erythematosus. J Rheumatol 16:918–925
18.
go back to reference Asherson RA, Higenbottam TW, Dinh Xuan AT, Khamashta MA, Hughes GR (1990) Pulmonary hypertension in a lupus clinic: experience with twenty-four patients. J Rheumatol 17:1292–1298 Asherson RA, Higenbottam TW, Dinh Xuan AT, Khamashta MA, Hughes GR (1990) Pulmonary hypertension in a lupus clinic: experience with twenty-four patients. J Rheumatol 17:1292–1298
19.
go back to reference Gonzalez-Crespo MR, Lopez-Fernandez JI, Usera G, Poveda MJ, Gomez-Reino JJ (1996) Outcome of silent lupus nephritis. Semin Arthritis Rheum 26:468–476 Gonzalez-Crespo MR, Lopez-Fernandez JI, Usera G, Poveda MJ, Gomez-Reino JJ (1996) Outcome of silent lupus nephritis. Semin Arthritis Rheum 26:468–476
20.
go back to reference Abu-Shakra M, Urowits MB, Gladman DD, Gough J (1995) Mortality studied in systemic lupus erythematosus. Results from a single study. I. Causes of death. J Rheumatol 22:1259–1264 Abu-Shakra M, Urowits MB, Gladman DD, Gough J (1995) Mortality studied in systemic lupus erythematosus. Results from a single study. I. Causes of death. J Rheumatol 22:1259–1264
21.
go back to reference Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, Mejia JC, Aydintug AO, Chwalinska-Sadowska H, de Ramon E, Fernadez-Nebro A, Galeazzi M, Valen M, Mathieu A, Houssiau F, Caro N, Alba P, Ramos-Casals M, Ingelmo M, Hughes GR, European Working Party on Systemic Lupus Erythematosus (2003) Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestation in a cohort of 1,000 patients. Medicine (Baltimore) 82:299–308 Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, Mejia JC, Aydintug AO, Chwalinska-Sadowska H, de Ramon E, Fernadez-Nebro A, Galeazzi M, Valen M, Mathieu A, Houssiau F, Caro N, Alba P, Ramos-Casals M, Ingelmo M, Hughes GR, European Working Party on Systemic Lupus Erythematosus (2003) Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestation in a cohort of 1,000 patients. Medicine (Baltimore) 82:299–308
22.
go back to reference Moroni G, Quaglini S, Maccario M, Banfi G, Ponticelli C (1996) “Nephritis flares” are predictors of bad long-term renal outcome in lupus nephritis. Kidney Int 50:2047–2053 Moroni G, Quaglini S, Maccario M, Banfi G, Ponticelli C (1996) “Nephritis flares” are predictors of bad long-term renal outcome in lupus nephritis. Kidney Int 50:2047–2053
23.
go back to reference Worrall JG, Snaith ML, Batchelor JR, Isenberg DA (1990) SLE: a rheumatological view. Analysis of the clinical features, serology and immunogenetics of 100 SLE patients during long-term follow-up. QJM 74:319–330 Worrall JG, Snaith ML, Batchelor JR, Isenberg DA (1990) SLE: a rheumatological view. Analysis of the clinical features, serology and immunogenetics of 100 SLE patients during long-term follow-up. QJM 74:319–330
24.
go back to reference Zampieri S, Iaccarino L, Ghirardello A, Tarricone E, Arienti S, Sarzi-Puttini, Gambari P, Doria A (2005) Systemic lupus erythematosus, atherosclerosis, and autoantibodies. Ann NY Acad Sci 1051:351–361 Zampieri S, Iaccarino L, Ghirardello A, Tarricone E, Arienti S, Sarzi-Puttini, Gambari P, Doria A (2005) Systemic lupus erythematosus, atherosclerosis, and autoantibodies. Ann NY Acad Sci 1051:351–361
25.
go back to reference Font J, Ramos-Casals M, Cervera R, Garcia-Carrasco M, Torras A, Siso A, Darnell A, Ingelmo M (2001) Cardiovascular risk factors and the long-term outcome of lupus nephritis. QJM 94:19–26 Font J, Ramos-Casals M, Cervera R, Garcia-Carrasco M, Torras A, Siso A, Darnell A, Ingelmo M (2001) Cardiovascular risk factors and the long-term outcome of lupus nephritis. QJM 94:19–26
26.
go back to reference Bijornadal L, Yin L, Granath F, Klareskog L, Ekbom A (2004) Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964–95. J Rheumatol 31:713–719 Bijornadal L, Yin L, Granath F, Klareskog L, Ekbom A (2004) Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964–95. J Rheumatol 31:713–719
27.
go back to reference Ward MM, Pyun E, Studenski S (1995) Causes of death in systemic lupus erythematosus. Long-term follow-up of an inception cohort. Arthritis Rheum 38:1492–1499 Ward MM, Pyun E, Studenski S (1995) Causes of death in systemic lupus erythematosus. Long-term follow-up of an inception cohort. Arthritis Rheum 38:1492–1499
28.
go back to reference Alarcon-Segovia D, Perez-Ruiz A, villa AR (2000) Long-term prognosis of anti-phospholipid syndrome in patients with systemic lupus erythematosus. J Autoimmun 15:157–161 Alarcon-Segovia D, Perez-Ruiz A, villa AR (2000) Long-term prognosis of anti-phospholipid syndrome in patients with systemic lupus erythematosus. J Autoimmun 15:157–161
29.
go back to reference Sthoeger ZM, Geltner D, Rider A, Bentwich Z (1987) Systemic lupus erythematosus in 49 Israeli males: a retrospective study. Clin Exp Rheumatol 5:233–240 Sthoeger ZM, Geltner D, Rider A, Bentwich Z (1987) Systemic lupus erythematosus in 49 Israeli males: a retrospective study. Clin Exp Rheumatol 5:233–240
30.
go back to reference Tyndall A, Saccardi R (2005) Haematopoietic stem cell transplantation in the treatment of severe autoimmune disease: results from phase I/II studies, prospective randomized trials and future directions. Clin Exp Immunol 141:1–9 Tyndall A, Saccardi R (2005) Haematopoietic stem cell transplantation in the treatment of severe autoimmune disease: results from phase I/II studies, prospective randomized trials and future directions. Clin Exp Immunol 141:1–9
Metadata
Title
Survival study by organ disorders in 306 Japanese patients with systemic lupus erythematosus: results from a single center
Authors
M. Funauchi
H. Shimadzu
C. Tamaki
T. Yamagata
Y. Nozaki
M. Sugiyama
S. Ikoma
K. Kinoshita
Publication date
01-01-2007
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 3/2007
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-006-0201-9

Other articles of this Issue 3/2007

Rheumatology International 3/2007 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.